Completed × Head and Neck Neoplasms × Radiotherapy × Clear all Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
Completed
57 enrolled
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
KEYNOTE-412
Phase 3 Completed
804 enrolled 20 charts
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Phase 1 Completed
9 enrolled
UPFRONT-NECK
Phase 3 Completed
65 enrolled
AACER
Phase 2 Completed
53 enrolled
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Phase 1 Completed
13 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 2 Completed
46 enrolled
Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
Phase 2 Completed
40 enrolled 69 charts
PREVLAR
Phase 2 Completed
53 enrolled 15 charts
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Phase 2 Completed
30 enrolled
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
RT-CASinHNC
Completed
907 enrolled
Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study
Completed
580 enrolled
Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
24 enrolled 11 charts
ASOG-HNO1
Phase NA Completed
51 enrolled
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Phase 1 Completed
50 enrolled
Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer
Phase 2 Completed
74 enrolled 8 charts
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
69 enrolled 7 charts
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Phase 2 Completed
G-DEFINER
Completed
247 enrolled
Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution
Phase NA Completed
21 enrolled
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Phase 1 Completed
20 enrolled
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
Phase 3 Completed
209 enrolled
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Phase 1/2 Completed
53 enrolled
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Phase 2 Completed
24 enrolled 16 charts
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
Phase 1/2 Completed
9 enrolled 11 charts
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
Phase 3 Completed
160 enrolled
Role of PET/MRI in Head and Neck Cancer
Completed
110 enrolled
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Phase 3 Completed
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Phase 2 Completed
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Phase 1/2 Completed
Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 1 Completed
20 enrolled 11 charts
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Phase 3 Completed
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Phase 1 Completed
3 enrolled
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
Phase 1 Completed
25 enrolled
The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients
Phase 2 Completed
60 enrolled
Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer
Phase NA Completed
49 enrolled
Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History
Phase 1 Completed
17 enrolled 8 charts
TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.
Phase 3 Completed
519 enrolled
TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
Phase 2 Completed
94 enrolled
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Completed
48 enrolled
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Phase 2 Completed
238 enrolled 12 charts
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 1 Completed
16 enrolled
MLN8237 in Head and Neck Cancer
Phase 1 Completed
9 enrolled
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
Phase 3 Completed
564 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
359 enrolled
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1/2 Completed
7 enrolled
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Phase 2 Completed
33 enrolled 15 charts